Back to Results
First PageMeta Content
Antifungals / F2G / Aspergillosis / Mycosis / Amphotericin B


PRESS RELEASE F2G Ltd announces the appointment of Ralf Schmid to the position of Chief Financial Officer MANCHESTER, UK – 11 JulyF2G Ltd, the UK-based antifungal drug discovery and development company, today a
Add to Reading List

Document Date: 2016-07-18 05:53:44

Open Document

File Size: 156,89 KB

Share Result on Facebook